Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Capstone Therapeutics Corp. (CAPS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
37.000.00 (0.00%)
At close: 10:10AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close37.00
Open37.00
Bid0.23 x 10000
Ask0.29 x 10000
Day's Range37.00 - 37.00
52 Week Range6.10 - 37.50
Volume4
Avg. Volume4
Market Cap5.832M
Beta (5Y Monthly)0.46
PE Ratio (TTM)3.18
EPS (TTM)11.64
Earnings DateAug 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CAPS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CAPSTONE THERAPEUTICS CORPORATI
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, Skyworks soars, Big Biopharma builds immunity to headwinds, and Baidu and the cloud; and Harmonic Drive Systems, Elekta, and Nabtesco.
    Rating
    Fair Value
    Economic Moat
    4 months agoMorningstar
View more
Advertisement
Advertisement